NEET PG clinical case walkthrough: a 58-year-old male with 30-pack-year smoking history presents with worsening dyspnea, purulent sputum, and SpO2 88%. Step-by-step COPD exacerbation diagnosis, GOLD classification, ABG interpretation, and management with MCQs.
Version 1.0 — Published April 2026
A 58-year-old male retired factory worker presents to the emergency department with worsening breathlessness for 5 days. He reports that he can no longer walk from his bed to the bathroom (a distance of 10 meters) without stopping to catch his breath. He describes increased sputum production — now thick, yellow-green, and approximately 2 tablespoons per episode (up from his usual clear mucoid sputum). He also reports low-grade fever (100.4 F) for 3 days and audible wheezing noticed by his wife.
He has smoked 20 bidi per day for 30 years (30 pack-year equivalent). He was diagnosed with "asthma" 8 years ago at a local clinic and uses a salbutamol inhaler intermittently. He has had 3 similar episodes in the past 18 months, the last requiring a 5-day hospital stay 4 months ago. He takes no regular medications and has not received any vaccinations.
Smoking history is the central anchor in this vignette. A 30-pack-year history in a male over 40 with progressive dyspnea and recurrent exacerbations points overwhelmingly to COPD rather than asthma. In India, COPD affects an estimated 55.3 million adults (Global Burden of Disease Study, 2019), with bidi smoking and biomass fuel exposure as the two dominant risk factors.
The misdiagnosis as "asthma" is deliberate in this stem — NEET PG frequently tests the asthma-COPD distinction in middle-aged smokers.
General examination:
Respiratory examination:
Cardiovascular: Loud P2 (suggesting pulmonary hypertension). No pedal edema currently (no cor pulmonale yet).
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Start practicing NEET PG MCQs with AI-powered explanations.
Start Free PracticeAvoid the 10 costliest medicine mistakes in NEET PG 2026: confused anemia types, wrong hepatitis serology, diabetes diagnostic errors, thyroid function mix-ups, murmur misidentification, antibiotic selection errors, nephrotic vs nephritic confusion, acid-base disorders, ABG misinterpretation, and autoimmune marker confusion.
NEET PG clinical case walkthrough: a young woman presents with heavy vaginal bleeding 2 hours post delivery. Step-by-step diagnosis and management of atonic postpartum hemorrhage including the 4 Ts, uterotonics, B-Lynch suture, and surgical escalation.
NEET PG clinical case walkthrough: an infant presents with clusters of flexion spasms on awakening and developmental regression. Step-by-step diagnosis and management of West syndrome with MCQs.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →Acute COPD exacerbation is the clinical anchor, but the differential for acute dyspnea in a chronic smoker includes several conditions that can mimic or coexist with COPD:
| Diagnosis | Points in favor | Points against |
|---|---|---|
| Acute COPD exacerbation | 30-pack-year smoker, recurrent episodes, barrel chest, hyperresonance, purulent sputum, SpO2 88% | None — all findings consistent |
| Pneumonia | Fever, purulent sputum, tachycardia | No focal consolidation signs (no bronchial breathing, no crepitations, no dullness) |
| Acute asthma | Wheezing, breathlessness, inhaler use | Age 58, 30-pack-year history, barrel chest, no atopic history, progressive course over years |
| Pneumothorax | Sudden dyspnea in COPD (bullae can rupture) | Bilateral hyperresonance (not unilateral), no absent breath sounds on one side |
| Pulmonary embolism | Tachycardia, dyspnea, hypoxia | Purulent sputum and fever suggest infection; no pleuritic chest pain, no DVT signs |
| Acute left ventricular failure | Dyspnea, tachycardia | No crackles, no S3, no raised JVP, hyperresonance not explained by LVF |
The combination of chronic smoking history + barrel chest + hyperresonance + purulent sputum increase + hypoxia is classic acute exacerbation of COPD. The Anthonisen criteria confirm the diagnosis severity.
Arterial blood gas (ABG) is the most critical investigation in acute COPD exacerbation — it determines management strategy.
This patient's ABG on room air:
ABG interpretation (step by step):
This ABG pattern — acidic pH with elevated PaCO2 and appropriately elevated HCO3 — is the classic NEET PG ABG for COPD exacerbation.
Other investigations:
Acute exacerbation of COPD (Anthonisen Type I, severe) with acute-on-chronic respiratory acidosis. Likely GOLD stage 3 (severe airflow limitation) based on clinical severity and history of recurrent exacerbations.
Anthonisen classification for this patient:
| Cardinal symptom | Present? |
|---|---|
| Increased dyspnea | Yes — cannot walk 10 meters |
| Increased sputum volume | Yes — 2 tablespoons per episode |
| Increased sputum purulence | Yes — yellow-green (was clear) |
All three cardinal symptoms are present = Type I (severe) exacerbation. This classification directly determines antibiotic indication — antibiotics are recommended for Type I and Type II exacerbations.
GOLD severity staging (for stable COPD, assessed after recovery):
| GOLD stage | FEV1 (% predicted) | Description |
|---|---|---|
| GOLD 1 | At or above 80% | Mild |
| GOLD 2 | 50-79% | Moderate |
| GOLD 3 | 30-49% | Severe |
| GOLD 4 | Below 30% | Very severe |
Management of acute COPD exacerbation follows a stepwise approach. The order matters — NEET PG tests the sequence, not just the drugs.
Repeat ABG after 1-2 hours of medical therapy. This is the key decision point that NEET PG tests:
| ABG result | Action |
|---|---|
| pH improved to above 7.35 | Continue medical management, monitor |
| pH 7.25-7.35 with persistent hypercapnia | Start NIV (BiPAP) — IPAP 10-14 cmH2O, EPAP 4-6 cmH2O |
| pH below 7.25 or deteriorating | Consider intubation and mechanical ventilation |
For this patient: pH 7.31 with PaCO2 58 mmHg after initial medical therapy qualifies for NIV. BiPAP reduces work of breathing, improves gas exchange, reduces intubation rates by 50%, and reduces in-hospital mortality by 20% (Plant et al., Lancet, 2000).
NIV contraindications (commonly tested):
Practice medicine MCQs on pulmonology and respiratory physiology to strengthen your COPD clinical reasoning. For a comprehensive review of medicine high-yield topics, see our NEET PG medicine guide.
After stabilization (usually 5-7 days for hospitalized patients):
Join 10,000+ NEET PG aspirants preparing smarter with AI.
Start Free Practice →COPD exacerbation is tested through four dominant patterns in NEET PG, contributing 2-3 questions per paper:
Pattern 1 — The ABG question: Given ABG values (pH, PaCO2, HCO3, PaO2), identify the acid-base disturbance. The trap: confusing acute respiratory acidosis (normal HCO3, very acidic pH) with acute-on-chronic (elevated HCO3 from chronic compensation, mildly acidic pH). Always calculate the expected HCO3 for the given PaCO2.
Pattern 2 — The oxygen therapy question: Target SpO2 in COPD is 88-92%. The most common wrong answer chosen is 94-98% (which applies to non-COPD patients). The stem may disguise this as "a patient with known COPD and CO2 retention" and ask which oxygen delivery device to use — the answer is Venturi mask for precise FiO2 control.
Pattern 3 — The NIV indication: A patient with COPD exacerbation and pH 7.28-7.34 despite initial bronchodilators. The answer is BiPAP. The trap: choosing invasive ventilation (intubation) too early — NIV is first-line when pH is between 7.25-7.35.
Pattern 4 — The Anthonisen classification: Three cardinal symptoms (increased dyspnea, sputum volume, sputum purulence). Antibiotics are indicated in Type I (all three) and Type II (two of three). Type III (one symptom) does not require antibiotics.
High-yield one-liners for last-day revision:
Respiratory tract infections cause 50-70% of COPD exacerbations. Bacterial infections (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) account for roughly half of infectious exacerbations, with viral infections (rhinovirus, influenza, RSV) causing most of the rest. Air pollution, non-adherence to inhalers, and pulmonary embolism are other important triggers tested in NEET PG.
The target SpO2 in COPD exacerbation is 88-92%, not the 94-98% used for most other conditions. COPD patients with chronic CO2 retention rely partly on hypoxic drive for respiration. Excessive oxygen (SpO2 above 92%) suppresses this drive, worsens hypercapnia, and can cause CO2 narcosis. This is one of the most frequently tested oxygen therapy concepts in NEET PG.
The Anthonisen criteria classify COPD exacerbation severity using three cardinal symptoms: increased dyspnea, increased sputum volume, and increased sputum purulence. Type I (severe) has all three symptoms. Type II (moderate) has two of three. Type III (mild) has one symptom plus at least one minor criterion (upper respiratory infection in past 5 days, fever, increased wheezing, increased cough, or heart rate/respiratory rate increase of 20% above baseline).
Non-invasive ventilation (BiPAP) is indicated when respiratory acidosis persists (pH 7.25-7.35, PaCO2 above 45 mmHg) despite optimal medical therapy including controlled oxygen and nebulized bronchodilators. NIV reduces intubation rates by 50% and mortality by 20% in moderate acidosis. Contraindications include pH below 7.25 (relative), facial trauma, inability to protect airway, and hemodynamic instability.
Antibiotics are indicated when at least two of three Anthonisen criteria are present, especially with increased sputum purulence. First-line options are amoxicillin-clavulanate, doxycycline, or a macrolide (azithromycin). For severe exacerbations or patients with risk factors for Pseudomonas (frequent exacerbations, FEV1 below 30%, recent hospitalization), respiratory fluoroquinolones (levofloxacin, moxifloxacin) or piperacillin-tazobactam are preferred.
Compensated COPD shows chronic respiratory acidosis with metabolic compensation: elevated PaCO2 (50-60 mmHg), near-normal pH (7.35-7.38), and elevated bicarbonate (28-34 mEq/L). Decompensated COPD (acute-on-chronic) shows acute worsening: higher PaCO2 (60-80+ mmHg), acidic pH (below 7.35), and bicarbonate that has not risen enough to compensate. The pH is the key differentiator — if pH is below 7.35 with elevated PaCO2, the acidosis is uncompensated.
GOLD classifies airflow limitation severity by post-bronchodilator FEV1/FVC ratio below 0.7 plus FEV1 percentage of predicted: GOLD 1 (mild) FEV1 at or above 80%, GOLD 2 (moderate) 50-79%, GOLD 3 (severe) 30-49%, GOLD 4 (very severe) below 30%. The 2024 GOLD report also uses the ABE assessment tool combining symptoms (mMRC/CAT scores) and exacerbation history to guide treatment escalation.
Systemic corticosteroids shorten recovery time, improve FEV1, and reduce treatment failure rates by 30-40%. The REDUCE trial (JAMA, 2013) showed 5 days of prednisolone 40 mg daily is as effective as 14 days. GOLD 2024 recommends 5-7 days of oral prednisolone 40 mg or IV methylprednisolone for hospitalized patients. Prolonged courses increase hyperglycemia and infection risk without additional benefit.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Strengthen your medicine subject coverage and build clinical reasoning by working through pulmonology vignettes on the NEETPGAI practice platform. Ready for unlimited AI-powered MCQs with detailed explanations? Explore NEETPGAI Pro.
For personalized study guidance on respiratory medicine and other high-yield topics, try the AI Tutor — it adapts to your weak areas and explains concepts the way a senior resident would.
Written by: NEETPGAI Editorial Team Reviewed by: Pending SME Review Last reviewed: April 2026
This article is reviewed by qualified medical professionals for clinical accuracy and exam relevance. For corrections or updates, contact the editorial team.